Collaboration Helps Drive Advancement
Making use of ultra-low endotoxin Cas9 from Aldevron
The latest research article from the Innovative Genomics Institute (IGI) at the University of California, Berkeley, highlights the collaboration between Aldevron with the laboratories of Nobel Laureate Dr. Jennifer Doudna and Dr. David Savage. Published in Molecular Therapy-Nucleic Acids, “Genome editing in the mouse brain with minimally immunogenic Cas9 RNPs,” shows how Aldevron generated ultra-low endotoxin Cas9 for IGI to enable a novel in vivo CRISPR delivery system, targeted directly into the brain for editing.
